Similar results were obtained from the analysis of p-MCM2/MCM2 level between healthy samples and all tumor in CRC group (3.48-fold increment, P < 0.001), and lung group (3.56-fold increment, P < 0.00). This evidence concerns the gene MCM2 and colorectal carcinoma.